P

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

Associate Director - Global Market Access & Pricing

Business & StrategyPosted on Nov 9
Full-timeWarren, NJ, USA

About the Job

Requirements

  • A master's degree in life sciences, pharmacy, health economics, business, or a related scientific discipline is required; an MSc, MPH, PhD, or equivalent advanced degree is acceptable.
  • At least 6 years of progressively responsible experience in Market Access, Pricing, Health Economics and Outcomes Research (HEOR), or related roles within the pharmaceutical, biotechnology, or related industry, including at least 5 years in global commercial organizations.
  • Experience developing value dossiers and supporting launch and lifecycle planning in a cross-functional environment.
  • Strong understanding of orphan drug pricing and global payor processes.
  • Knowledge of and hands-on experience in health outcomes and pricing.
  • Demonstrated ability to lead the development of a global value proposition and value dossier for orphan or specialty indications.
  • Knowledge of international health care systems and pricing and reimbursement requirements.
  • Demonstrated understanding of the dynamics of international health care systems and financing mechanisms.
  • Demonstrated ability to collaborate in a fast-paced, matrixed team environment with internal and external team members.
  • Demonstrated experience working with and supervising external vendors.
  • Experience in pharmaceutical product development, pricing, or commercialization, which may be concurrent with technical health outcomes and economics strategy experience.
  • Proficiency with Microsoft Office.
  • Fluency in spoken and written English.

Responsibilities

  • Develop and execute global pricing and market access strategies for assigned assets in partnership with Commercial, Medical, HEOR, and Regulatory.
  • Lead payer and health technology assessment (HTA) landscape assessments and targeted payer research to shape the value proposition, define evidence needs, and inform clinical development and evidence plans.
  • Create and deliver core global access and pricing deliverables, including Global Value Dossiers (GVDs), negotiation strategy guidance, pricing recommendations, and affiliate training and enablement materials.
  • Support HTA submissions and dossiers and reimbursement negotiations, and monitor evolving policy changes, competitor activity, and pricing and access dynamics to inform strategy updates.
  • Perform pricing analytics across gross-to-net drivers, contracting and discounting assumptions, price corridors, and international reference pricing (IRP) impacts.
  • Manage external vendors, consultants, and budget as needed to deliver access and pricing workstreams.
  • Partner with regional and local Market Access leads and HEOR to support regional and local access needs and assess product coverage and reimbursement gaps.
  • Provide global market access recommendations for late-stage product development and the global commercialization of new products.
  • Manage assigned budget in alignment with department budget guidance.
  • Perform other tasks and assignments as needed and specified by management.

Desired Qualifications

  • Experience in rare disease or orphan products and related consulting.
  • Advanced degree, including PhD, master's, or MBA.
  • Experience supporting the commercialization of an orphan or rare-disease product.
  • Experience contributing to late-stage product development and the global commercialization of new products.

About the Company

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

PTC Therapeutics develops and commercializes treatments for rare genetic disorders worldwide, leveraging RNA biology and post-transcriptional control. Its portfolio includes Translarna (ataluren) for nonsense-mutant Duchenne muscular dystrophy, Evrysdi (risdiplam) for spinal muscular atrophy, Emflaza (deflazacort) for DMD, and Upstaza for AADC deficiency, among others. The company uses an integrated model spanning discovery, clinical development, manufacturing, and global commercialization, with operations in 50+ countries and a European base in Dublin. Its goal is to provide safe, effective therapies for patients with limited treatment options and to grow a robust pipeline in rare diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Warren Township, New Jersey
Founded
1998

Recently Posted Jobs

Explore more opportunities at PTC Therapeutics

See more jobs